Cardax Valuation
| CDXI Stock | USD 0.0002 0.00 0.00% |
Cardax seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Cardax Inc from analyzing the firm fundamentals such as Price To Earning of (22.00) X, return on asset of -1.13, and Current Valuation of 5.34 M as well as examining its technical indicators and probability of bankruptcy. In general, most investors favor purchasing undervalued instruments and trading away overvalued instruments since, at some point, asset prices and their ongoing real values will blend.
Overvalued
Today
Please note that Cardax's price fluctuation is very steady at this time. Calculation of the real value of Cardax Inc is based on 3 months time horizon. Increasing Cardax's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Cardax Inc is useful when determining the fair value of the Cardax pink sheet, which is usually determined by what a typical buyer is willing to pay for full or partial control of Cardax. Since Cardax is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Cardax Pink Sheet. However, Cardax's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 | Naive 2.0E-4 |
The real value of Cardax Pink Sheet, also known as its intrinsic value, is the underlying worth of Cardax Inc Company, which is reflected in its stock price. It is based on Cardax's financial performance, assets, liabilities, growth prospects, management team, or industry conditions. The intrinsic value of Cardax's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Cardax's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Cardax Inc helps investors to forecast how Cardax pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Cardax more accurately as focusing exclusively on Cardax's fundamentals will not take into account other important factors: Cardax Valuation Ratios as Compared to Competition
Comparative valuation techniques use various fundamental indicators to help in determining Cardax's current stock value. Our valuation model uses many indicators to compare Cardax value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cardax competition to find correlations between indicators driving Cardax's intrinsic value. More Info.Cardax Inc is rated below average in price to earning category among related companies. It is rated fifth in price to sales category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cardax by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cardax's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cardax's earnings, one of the primary drivers of an investment's value.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Cardax's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Cardax and how it compares across the competition.
About Cardax Valuation
The pink sheet valuation mechanism determines the current worth of Cardax Inc on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Cardax Inc. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Cardax Inc based exclusively on its fundamental and basic technical indicators. By analyzing Cardax's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Cardax's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardax. We calculate exposure to Cardax's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cardax's related companies.Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It is also developing CDX-101, an astaxanthin pharmaceutical candidate for cardiovascular inflammation and dyslipidemia, with a target indication of severe hypertriglyceridemia and CDX-301, a zeaxanthin pharmaceutical candidate for macular degeneration. Cardax operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 10 people.
8 Steps to conduct Cardax's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Cardax's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Cardax's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Cardax's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Cardax's revenue streams: Identify Cardax's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Cardax's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Cardax's growth potential: Evaluate Cardax's management, business model, and growth potential.
- Determine Cardax's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Cardax's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Cardax Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Cardax does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 744.6 K | |
| Retained Earnings | -72.1 M | |
| Retained Earnings Total Equity | -72.1 M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cardax Inc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Cardax Pink Sheet analysis
When running Cardax's price analysis, check to measure Cardax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardax is operating at the current time. Most of Cardax's value examination focuses on studying past and present price action to predict the probability of Cardax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardax's price. Additionally, you may evaluate how the addition of Cardax to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |